Pancreatic Cancer Research

ResearcherTakeda Oncology (United States)No recent work listed

Thea Kalebic

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5001816887. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

  1. Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models. Co-author DOI 10.2174/2212697x05666180516120907↗
  2. A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing … Last author DOI 10.1007/s10637-017-0473-9↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wells A. Messersmith · 2 shared papers, 2017–2018 · strength 0.12
  2. John J. Arcaroli · 1 shared paper, 2018 · strength 0.07
  3. Todd M. Pitts · 1 shared paper, 2018 · strength 0.07
  4. Anna Schreiber · 1 shared paper, 2018 · strength 0.07
  5. Jason Edward Faris · 1 shared paper, 2017 · strength 0.05
  6. Khaldoun Almhanna · 1 shared paper, 2017 · strength 0.05
  7. Jean‐Luc Van Laethem · 1 shared paper, 2017 · strength 0.05
  8. Naureen Starling · 1 shared paper, 2017 · strength 0.05
  9. Carmen Guillén‐Ponce · 1 shared paper, 2017 · strength 0.05
  10. Jaime Feliú · 1 shared paper, 2017 · strength 0.05
  11. Richard A Hubner · 1 shared paper, 2017 · strength 0.05
  12. Johanna C. Bendell · 1 shared paper, 2017 · strength 0.05
  13. Teresa Mercade Macarulla · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.